The shares of large pharmaceutical groups specializing in vaccines, in Europe and the United States, fell on the stock market on Friday, due to the probable appointment to the United States Department of Health of Robert F. Kennedy Jr., notoriously skeptical of -with regard to vaccines.
• Also read: Here are Trump’s main enemies who could taste his vengeance
Around 12 p.m. GMT, the French Sanofi lost 2.82% on the Paris Stock Exchange and the Franco-Austrian Valneva fell 5.64% in a market down 0.16%. On the London Stock Exchange, Astrazeneca lost 2.47% and GSK 3.07%, in a stable market.
On Wall Street on Thursday, Pfizer finished down 2.62% and Moderna 5.62%. Johnson & Johnson (J&J) closed down 0.89% and Merck lost 0.14%.
The Danish pharmaceutical group Novo Nordisk, which notably manufactures treatments for diabetes and obesity Ozempic/Wegovy, fell 4.25% in Copenhagen on Friday.
Future President of the United States Donald Trump announced Thursday that he wanted to entrust the Department of Health to Robert F. Kennedy Jr.
Under the leadership of RFK Jr, the Ministry of Health “will play a large role in ensuring that everyone is protected from dangerous chemicals, pollutants, pesticides, pharmaceuticals and food additives,” wrote the future 47th president in appointing the nephew of John F. Kennedy.
This former environmental law lawyer with no scientific training has propagated conspiracy theories, both on Covid-19 vaccines and on alleged links between vaccination and autism. He also calls for an end to the addition of fluoride to running water, although it is considered a great health success in the fight against dental caries.
Canada
